{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:38:18Z","timestamp":1766137098525,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: A considerable increase in the levels of adenoviral diseases among both adults and children necessitate the development of effective methods for its prevention and treatment. The synthesis of the new fluorinated 1,2,3-triazoles, and the study of the mechanisms of their action, are promising for the development of efficient antiviral drugs of our time. Materials and Methods: Antiviral activity and cell cytotoxic effect of 2-(3-chlorotetrahydrofuran-2-yl)-4-tosyl-5-(perfluoropropyl)-1,2,3-triazole (G29) were determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. The influence of the compound on the infectivity of human adenovirus type 5 (HAdV-5) was carried out via the cytomorphology method. The influence of the compound on the cell cycle under a condition of adenovirus infection was studied using flow cytometric analysis of propidium iodide-stained cells. Results: It was found that G29 suppressed HAdV-5 reproduction by 50% in concentrations of 37 \u03bcg\/mL. Furthermore, the compound reduced the titer of virus obtained de novo, and inhibited HAdV-5 inclusion bodies formation by 84\u201390%. The use of fluorinated compounds under the conditions of adenovirus infection decreased the number of apoptotic cells by 11% and the number of cells in S phase by 21\u201342% compared to the profile of infected cells. Conclusions: The fluorinated compound G29 showed moderate activity against HAdV-5 based on several mechanisms. It led to the normalization of the life cycle of cells infected with adenovirus to the level of non-infected cells and caused the obstruction of HAdV-5 reproduction, inducing the formation of non-infectious virus progeny.<\/jats:p>","DOI":"10.3390\/medicina54050081","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T10:43:45Z","timestamp":1541414625000},"page":"81","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-Adenoviral Activity of 2-(3-Chlorotetrahydrofuran-2-yl)-4-Tosyl-5-(Perfluoropropyl)-1,2,3-Triazole"],"prefix":"10.3390","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-2492","authenticated-orcid":false,"given":"Liubov","family":"Biliavska","sequence":"first","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 154, Zabolotnogo str., 03143 Kyiv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-7103","authenticated-orcid":false,"given":"Yuliia","family":"Pankivska","sequence":"additional","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 154, Zabolotnogo str., 03143 Kyiv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0349-7174","authenticated-orcid":false,"given":"Olga","family":"Povnitsa","sequence":"additional","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 154, Zabolotnogo str., 03143 Kyiv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0892-772X","authenticated-orcid":false,"given":"Svitlana","family":"Zagorodnya","sequence":"additional","affiliation":[{"name":"Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 154, Zabolotnogo str., 03143 Kyiv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganna","family":"Gudz","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry, National Academy of Sciences of Ukraine, 5, Murmanska str., 02660 Kyiv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-873X","authenticated-orcid":false,"given":"Yuriy","family":"Shermolovich","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry, National Academy of Sciences of Ukraine, 5, Murmanska str., 02660 Kyiv, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","article-title":"Human adenovirus: Viral pathogen with increasing importance","volume":"4","author":"Ghebremedhin","year":"2014","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.3390\/ph3103343","article-title":"Anti-Viral Drugs for Human Adenoviruses","volume":"3","author":"Waye","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved Antiviral Drugs over the Past 50 Years","volume":"29","author":"Li","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/srep01812","article-title":"Molecular evolution of human adenoviruses","volume":"3","author":"Robinson","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.2174\/0929867322666150625094705","article-title":"Curious (old and new) antiviral nucleoside analogues with intriguing therapeutic potential","volume":"22","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4155\/fmc-2017-0095","article-title":"Fluorinated nucleoside as an important class of anticancer and antiviral agents","volume":"9","author":"Cavaliere","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_8","unstructured":"(2014, August 17). ATCC\u00ae ANIMAL CELL CULTURE GUIDE. Available online: http:\/\/www.uab.cat\/doc\/ATCCguide."},{"key":"ref_9","first-page":"14C.1.1","article-title":"Human adenoviruses: Propagation, purification, quantification, and storage","volume":"1","author":"Green","year":"2006","journal-title":"Curr. Protoc. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1080\/15257770.2011.602654","article-title":"Synthesis and Biological Activity of the Nucleoside Analogs Based on Polyfluoroalkyl-Substituted 1,2,3-Triazoles","volume":"30","author":"Kanishchev","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the pass online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocycl. Compd."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and surviral: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nbt.2009.03.007","article-title":"Recent advancements for the evaluation of antiviral activities of natural products","volume":"25","author":"Chattopadhyay","year":"2009","journal-title":"New Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wold, W., and Tollefson, A. (2007). Adenovirus Methods and Protocols, Humana Press Inc.. [2nd ed.].","DOI":"10.1007\/978-1-59745-277-9"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/1516-635X1703275-280","article-title":"In Vitro Antiviral Activities of Extracts of Plants of The Brazilian Cerrado against the Avian Metapneumovirus (aMPV)","volume":"17","author":"Kohn","year":"2015","journal-title":"Braz. J. Poult. Sci."},{"key":"ref_16","unstructured":"London Research Institute (2014, May 25). Propidium Iodide Cell Cycle Staining Protocol. Available online: http:\/\/www.biolegend.com\/media_assets\/support_protocol\/PICell20Cycle20Staining20Protocol.pdf."},{"key":"ref_17","unstructured":"Darzynkiewicz, Z., Crissman, H.A., and Robinson, J.P. (2011). Methods in Cell Biology: Cytometry, Academic Press. [3rd ed.]. ISBN-10: 0123997151, ISBN-13: 978-0123997159."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Westwell, A.D. (2015). Fluorinated Pharmaceuticals: Advances in Medicinal Chemistry, Future Science Ltd.","DOI":"10.4155\/9781909453968"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Trapp-Fragnet, L., Bencherit, D., Chabanne-Vautherot, D., Le Vern, Y., Remy, S., Boutet-Robinet, E., Mirey, G., Vautherot, J.F., and Denesvre, C. (2016). Cell Cycle Modulation by Marek\u2019s Disease Virus: The Tegument Protein VP22 Triggers S-Phase Arrest and DNA Damage in Proliferating Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100004"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/viro.1998.9102","article-title":"Human Cells Arrest in S Phase in Response to Adenovirus 12 E1A","volume":"244","author":"Grand","year":"1998","journal-title":"Virology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/bp070198s","article-title":"Monitoring of the Adenovirus Production Process by Flow Cytometry","volume":"24","author":"Sandhu","year":"2008","journal-title":"Biotechnol. Prog."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12977-016-0254-0","article-title":"Dual anti-HIV mechanism of clofarabine","volume":"13","author":"Daly","year":"2016","journal-title":"Retrovirology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.2174\/09298673113209990178","article-title":"A novel promising therapeutic option against hepatitis C virus: An oral nucleotide NS5B polymerase inhibitor sofosbuvir","volume":"20","author":"Gentile","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_24","first-page":"25","article-title":"The role of protein kinase CK2 in the regulation of oncogenesis, apoptosis and cellular stress response","volume":"2","author":"Volynets","year":"2007","journal-title":"Ukr. Bioorg. Acta"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/scel.1994.1047","article-title":"Protein kinases and cell cycle control","volume":"5","author":"Pines","year":"1994","journal-title":"Semin. Cell Biol."},{"key":"ref_26","first-page":"39","article-title":"Inhibitors of protein kinase CK2","volume":"1","author":"Dubinina","year":"2004","journal-title":"Ukr. Bioorg. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/15257770008033000","article-title":"Design, synthesis, and antiviral evaluation of 2deoxyDribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections","volume":"19","author":"Zou","year":"2000","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/54\/5\/81\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:28:06Z","timestamp":1760196486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/54\/5\/81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["medicina54050081"],"URL":"https:\/\/doi.org\/10.3390\/medicina54050081","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2018,11,5]]}}}